Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor

Rita Costa, Frederico Ferreira-da-Silva, Maria J. Saraiva et al. · 2008

Read Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor by Rita Costa, Frederico Ferreira-da-Silva, Maria J. Saraiva et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002899.txt.

Description

Rita Costa, Frederico Ferreira-da-Silva, Maria Saraiva and co-authors studied how the protein transthyretin guards against amyloid beta in 2008. In Alzheimer's disease, amyloid beta peptide builds up in the brain. Transthyretin is a four-part protein made mainly in the liver and in a fluid-making part of the brain.

Published in PLOS ONE, the work reports that transthyretin protects by cutting the peptide, and that a protease blocker called a Kunitz inhibitor can stop that cutting. That gives a concrete mechanism, not just a link. It also suggests a path that future Alzheimer's treatments might try to strengthen.

Catalog record

CREATORRita Costa, Frederico Ferreira-da-Silva, Maria J. Saraiva et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002899

Browse the full library · About the Tower of Babel